Skip to main content
Guidance

Flu vaccination programme 2026 to 2027: healthcare practitioners

Guidance for healthcare practitioners on the national influenza immunisation programme 2026 to 2027.

Updates to this page

From:
UK Health Security Agency
Published:
13 August 2021
Last updated:
27 August 2026
Show all updates

  1. New section 'Prioritisation of adult IIV vaccines for 2026 to 2027 (update 26 August 2026)' added to clarify prioritisation of certain vaccines due to issues in vaccine supply and availability.

  2. Updated for the 2026 to 2027 flu season.

  3. New Common Issue added: Inadvertent administration of the recombinant inactivated influenza vaccine (IIVr) to a child under 18 years

  4. Updated for the 2025 to 2026 flu season.

  5. The wording under CI8 has been updated to reflect the change from September 2024 to licensed age indication for aQIV vaccine, for the 2024 to 2025 season.

  6. The wording under CI7 has been amended to reference change from September 2024 to licensed age indication for aQIV vaccine, for the 2024 to 2025 season. The URL in references 23 and 24 has also been updated.

  7. Updated for the 2024 to 2025 flu season.

  8. Corrected year in table 2.

  9. Added 2023 to 2024 guidance.

  10. Updated wording in LAIV and pregnancy section and added information about interval between Novavax COVID-19 vaccine and influenza vaccine.

  11. Added 'Flu vaccination programme 2022 to 2023: information for healthcare practitioners'.

  12. First published.

Applies to England

Documents

Flu vaccination programme 2026 to 2027: information for healthcare practitioners

HTML

Details

This document includes information on:

  • the national influenza programme recommendations for 2026 to 2027
  • the inactivated flu vaccines available for 2026 to 2027
  • the live attenuated influenza vaccine (LAIV)
  • common vaccination issues

Sign up for emails or print this page

Related content